Prescription drug · ANDA
Sildenafil NDC 71209-106
Sildenafil citrate 25 mg/1 · Tablet, Film coated · Oral · Cadila Pharmaceuticals Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71209-106-01 | 71209010601 | 30 TABLET, FILM COATED in 1 BOTTLE (71209-106-01)Marketed from Dec 1, 2023 | |
| 71209-106-05 | 71209010605 | 100 TABLET, FILM COATED in 1 BOTTLE (71209-106-05)Marketed from Dec 1, 2023 | |
| 71209-106-11 | 71209010611 | 1000 TABLET, FILM COATED in 1 BOTTLE (71209-106-11)Marketed from Dec 1, 2023 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Sildenafil
- Generic name (nonproprietary)
- sildenafil
- Active ingredients
- Sildenafil citrate — 25 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 218045
- Marketing start
- Listing expires
- Other FDA classes
- Phosphodiesterase 5 Inhibitors (Mechanism)
- Identifiers
- Product ID 71209-106_eff134c4-3240-4132-b9ea-118ce1fa719aSPL ID eff134c4-3240-4132-b9ea-118ce1fa719aSPL set ID c079fc41-7b9a-499d-88ea-86ccb65c828dRxCUI 312950, 314228, 314229UNII BW9B0ZE037UPC 0371209108010, 0377209102119, 0371209106054, 0371209107051, 0371209106016, 0371209107112, 0371209106115
- Pharmacologic class
- Phosphodiesterase 5 Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471209010601followed by a unit qualifier and the quantityPackage 71209-0106-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Sildenafil tablets are indicated for the treatment of erectile dysfunction. Sildenafil tablets are phosphodiesterase-5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction (ED) (1)
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 218045
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Sildenafil | Sildenafil citrate 100 mg/1 | Tablet, Film coatedOral | Cadila Pharmaceuticals Limited | 71209-108 |
| Sildenafil | Sildenafil citrate 50 mg/1 | Tablet, Film coatedOral | Cadila Pharmaceuticals Limited | 71209-107 |
| Sildenafil | Sildenafil citrate 100 mg/1 | Tablet, Film coatedOral | Modavar Pharmaceuticals LLC | 72241-071 |
| Sildenafil | Sildenafil citrate 25 mg/1 | Tablet, Film coatedOral | Modavar Pharmaceuticals LLC | 72241-069 |
| Sildenafil | Sildenafil citrate 50 mg/1 | Tablet, Film coatedOral | Modavar Pharmaceuticals LLC | 72241-070 |